SAVA Cassava Sciences, Inc.

Cassava Sciences, Inc. is a biopharmaceutical company that develops novel drugs.

$81.42  +3.86 (4.98%)
As of 06/24/2021 15:59:52 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  01/11/2000
Outstanding shares:  40,008,654
Average volume:  2,837,900
Market cap:   $3,105,871,810
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    14817C107
ISIN:        US14817C1071
Sedol:      BJVLKZ9

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   11.04
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%